Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2019, Stoic Venture Capital is based in Sydney, Australia, and focuses on partnering with scientists and engineers to commercialize research. The firm manages a portfolio of 9 companies and typically invests between $100,000 and $1 million. Stoic VC aims to address significant global challenges through technology development.
Stoic VC invests in sectors such as healthcare, biotech, AI, and climate solutions. They target startups that have demonstrated proof of concept (POC) in their research, providing funding from $100,000 to $1 million. The firm emphasizes transforming research into commercially viable products.
Notable portfolio companies include Kinoxis, developing therapeutics for cognitive disorders; Neurode, a platform for non-invasive neurostimulation; BioScout, which prevents airborne diseases in agriculture; and ENA Respiratory, creating a universal nasal spray for viral infections. Other companies include Cardihab, Ferronova, Exonate, PERKii, and OccuRx.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.